Compounds > (5-(3-thienyl)tetrazol-1-yl)acetic acid
Page last updated: 2024-12-10
(5-(3-thienyl)tetrazol-1-yl)acetic acid
Description
(5-(3-thienyl)tetrazol-1-yl)acetic acid is a **heterocyclic compound** with a complex structure involving a tetrazole ring attached to a thiophene ring, further connected to an acetic acid group.
**Structure:**
* **Tetrazole Ring:** A five-membered ring containing four nitrogen atoms and one carbon.
* **Thiophene Ring:** A five-membered ring containing one sulfur atom and four carbon atoms.
* **Acetic Acid Group:** A carboxylic acid group (-COOH) attached to the tetrazole ring.
**Importance in Research:**
While (5-(3-thienyl)tetrazol-1-yl)acetic acid itself is not a well-known compound with extensive research, its structure and components are relevant in various research areas:
* **Pharmaceutical Chemistry:**
* **Tetrazoles:** Are often incorporated into drug molecules due to their ability to act as bioisosteres (mimic the properties of other functional groups).
* **Thiophenes:** Are known to enhance bioavailability and modify the pharmacological properties of drugs.
* **Carboxylic Acid:** A common functional group in drug molecules that can influence their activity and target interactions.
* **Materials Science:**
* **Heterocycles:** Can exhibit unique electronic and optical properties, making them useful in developing new materials for applications like organic electronics, sensors, and photovoltaics.
**Possible Research Directions:**
* **Synthesis and Characterization:** Synthesizing and characterizing this specific compound could provide valuable insights into its chemical properties and potential for applications.
* **Biological Activity:** Evaluating its potential biological activities could reveal its suitability for drug discovery or other therapeutic applications.
* **Material Science:** Investigating its properties for use in organic electronics or other materials science applications.
**Important Note:** The specific compound mentioned is not widely studied. Further research is required to determine its precise properties and potential applications.
(5-(3-thienyl)tetrazol-1-yl)acetic acid: structure given in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
Cross-References
ID Source | ID |
PubMed CID | 3035658 |
SCHEMBL ID | 4347946 |
MeSH ID | M0216141 |
Synonyms (23)
Synonym |
1h-tetrazole-1-acetic acid, 5-(3-thienyl)- |
5-(3-thienyl)tetrazol-1-ylacetic acid |
5-(3-thienyl)-1h-tetrazole-1-acetic acid |
(5-(3-thienyl)tetrazol-1-yl)acetic acid |
SCHEMBL4347946 |
2-(5-thiophen-3-yltetrazol-1-yl)acetic acid |
134717-73-0 |
1h-tetrazole-1-aceticacid, 5-(3-thienyl)- |
AKOS015155635 |
[5-(3-thienyl)tetrazol-1-yl]acetic acid |
[5-(3-thienyl) tetrazol-1-yl] acetic acid |
[5-(3-thienyl) tetrazol-1-yl]acetic acid |
DDVAZOPRCKAYOV-UHFFFAOYSA-N |
[5-(3-thienyl)tetrazol-1-yl] acetic acid |
DTXSID10158900 |
CCG-352908 |
wp 921 |
2-[5-(3-thienyl)-1-tetrazolyl]acetic acid |
wp921 |
2-[5-(thiophen-3-yl)-1h-1,2,3,4-tetrazol-1-yl]acetic acid |
2-[5-(thiophen-3-yl)-1h-1,2,3,4-tetrazol-1-yl]aceticacid |
EN300-252256 |
Z1269222962 |
Research
Studies (10)
Timeframe | Studies, This Drug (%) | All Drugs % |
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 9 (90.00) | 18.2507 |
2000's | 1 (10.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Market Indicators
Research Demand Index: 11.76
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
Metric | This Compound (vs All) |
---|
Research Demand Index | 11.76 (24.57) | Research Supply Index | 2.40 (2.92) | Research Growth Index | 4.16 (4.65) | Search Engine Demand Index | 0.00 (26.88) | Search Engine Supply Index | 0.00 (0.95) |
| |
Study Types
Publication Type | This drug (%) | All Drugs (%) |
Trials | 0 (0.00%) | 5.53% |
Reviews | 0 (0.00%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 10 (100.00%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |